Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

Data as of Oct 17
 +0.011 / +3.43%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Hemispherx Biopharma, Inc. is a biopharmaceutical company, which engages in treating and preventing chronic viral and immune-based disorders through the development and manufacturing of compounds that enhance the natural immune system of the human body. Its products include Alferon N Injection and the experimental immunotherapeutic/antiviral Ampligen. Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. Ampligen includes application as a treatment for Chronic Fatigue Syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Philadelphia, PA.

Contact Information

Hemispherx Biopharma, Inc.
One Penn Center
Philadelphia Pennsylvania 19103
P:(215) 988-0080
Investor Relations:
(518) 398-6222



Mutual fund holders3.09%
Other institutional2.81%
Individual stakeholders2.32%

Top Executives

William A. CarterChairman, President, Chief Executive Officer & CSO
Wayne S. SpringateSenior Vice President-Operations
Thomas Kenwood EquelsExecutive Vice Chairman, CFO & Secretary
David R. StrayerCMO, Medical Director & Head-Regulatory Affairs
Ralph Christopher CavalliVice President-Quality Control

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.